Skip to main content
. 2018 Aug 8;10(8):1033. doi: 10.3390/nu10081033

Table 1.

Characteristics of the Mitchelstown cohort (n = 1992) by E-DII median.

Min and Max of E-DII Scores <Median E-DII
−5.10 to −1.28
>Median E-DII
−1.28 to 3.68
p
E-DII −2.51 ± 0.02 −0.06±0.03 <0.001
Age (years) 59.9 ± 0.17 59.5±0.17 0.04
Gender (% male) 38.6 59.4 <0.001
BMI (kg/m2) 28.40 ± 0.15 28.72 ± 0.15 0.12
Waist (cm) 95.48 ± 0.41 98.32 ± 0.41 <0.001
Total cholesterol (mmol/L) 5.25 ± 0.03 5.31 ± 0.03 0.24
LDL-C (mmol/L) 3.13 ± 0.03 3.22 ± 0.03 0.04
HDL-C (mmol/L) 1.48 ± 0.01 1.42 ± 0.01 <0.001
Triglycerides (mmol/L) 1.34 ± 0.02 1.45 ± 0.03 0.004
FPG (mmol/L) 5.17 ± 0.04 5.21 ± 0.04 0.03
Insulin (µIU/mL) 11.02 ± 0.29 12.10 ± 0.35 0.06
HOMA 2.71 ± 0.09 2.98 ± 0.10 0.06
QUICKI 0.28 ± 0.002 0.27 ± 0.002 0.26
SBP (mm Hg) 128.5 ± 0.52 130.6 ± 0.54 0.005
DBP (mm Hg) 79.9 ± 0.31 80.5 ± 0.31 0.17
Current smokers (%) 12.6 16.7 0.008
Moderate and heavy alcohol consumers (%) 78.9 80.5 0.49
Low intensity physical activity (%) 43.5 52.9 <0.001
Type 2 diabetes (%) 8.9 8.5 0.71
CVD (%) 10.7 10.1 0.66
MetS (%) 21.5 25.4 0.04
Obesity (%) 36.3 34.0 0.14
Hypertension (%) 46.5 43.7 0.24
Anti-inflammatory medication (%) 4.1 4.3 0.82
Lipid lowering medication (%) 6.9 6.4 0.65

Continuous variables are expressed as means ± SEM; categorical variables are expressed as percentages. p was derived from Students t-tests and non-parametric tests for continuous variables and Chi-Square test for categorical variables. %: percentage; E-DII: Energy-adjusted dietary inflammatory index; DBP: Diastolic blood pressure; LDL-C: LDL cholesterol; HDL-C: HDL cholesterol; FPG: fasting plasma glucose; HOMA: Homeostasis model assessment; QUICKI: Quantitative insulin-sensitivity check index; CVD: cardiovascular disease; MetS: metabolic syndrome.